334 related articles for article (PubMed ID: 35732818)
21. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease.
Lemberg DA; Clarkson CM; Bohane TD; Day AS
J Gastroenterol Hepatol; 2005 Nov; 20(11):1696-700. PubMed ID: 16246188
[TBL] [Abstract][Full Text] [Related]
22. Combined segregation and linkage analysis of inflammatory bowel disease in the IBD1 region using severity to characterise Crohn's disease and ulcerative colitis. On behalf of the GISC.
Forabosco P; Collins A; Latiano A; Annese V; Clementi M; Andriulli A; Fortina P; Devoto M; Morton NE
Eur J Hum Genet; 2000 Nov; 8(11):846-52. PubMed ID: 11093274
[TBL] [Abstract][Full Text] [Related]
23. Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease.
Qv L; Mao S; Li Y; Zhang J; Li L
Front Cell Infect Microbiol; 2021; 11():755650. PubMed ID: 34900751
[TBL] [Abstract][Full Text] [Related]
24. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
25. Role of mucosal dendritic cells in inflammatory bowel disease.
Niess JH
World J Gastroenterol; 2008 Sep; 14(33):5138-48. PubMed ID: 18777590
[TBL] [Abstract][Full Text] [Related]
26. Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity.
Zhong G; He C; Wang S; Lin C; Li M
Front Immunol; 2023; 14():1241262. PubMed ID: 37720208
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory bowel disease: between genetics and microbiota.
Younis N; Zarif R; Mahfouz R
Mol Biol Rep; 2020 Apr; 47(4):3053-3063. PubMed ID: 32086718
[TBL] [Abstract][Full Text] [Related]
28. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
Vucelic B
Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
[TBL] [Abstract][Full Text] [Related]
30. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
31. Understanding inborn errors of immunity: A lens into the pathophysiology of monogenic inflammatory bowel disease.
Ouahed JD
Front Immunol; 2022; 13():1026511. PubMed ID: 36248828
[TBL] [Abstract][Full Text] [Related]
32. Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's Disease.
Grim C; Noble R; Uribe G; Khanipov K; Johnson P; Koltun WA; Watts T; Fofanov Y; Yochum GS; Powell DW; Beswick EJ; Pinchuk IV
J Crohns Colitis; 2021 Aug; 15(8):1362-1375. PubMed ID: 33506258
[TBL] [Abstract][Full Text] [Related]
33. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
34. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
35. Histopathology of inflammatory bowel disease - Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC).
Villanacci V; Reggiani-Bonetti L; Caprioli F; Saragoni L; Salviato T; Mescoli C; Canavese G; Manenti S; Spada E; Baron L; Leoncini G; Cadei M; Battista S; Armuzzi A
Dig Liver Dis; 2020 Mar; 52(3):262-267. PubMed ID: 31884010
[TBL] [Abstract][Full Text] [Related]
36. Immune Cell Landscaping Reveals Distinct Immune Signatures of Inflammatory Bowel Disease.
Bai X; Liu W; Chen H; Zuo T; Wu X
Front Immunol; 2022; 13():861790. PubMed ID: 35371090
[TBL] [Abstract][Full Text] [Related]
37. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
Merga Y; Campbell BJ; Rhodes JM
Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
[TBL] [Abstract][Full Text] [Related]
38. TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease.
Furfaro F; Alfarone L; Gilardi D; Correale C; Allocca M; Fiorino G; Argollo M; Zilli A; Zacharopoulou E; Loy L; Roda G; Danese S
Curr Drug Targets; 2021; 22(7):760-769. PubMed ID: 33475057
[TBL] [Abstract][Full Text] [Related]
39. Morphology of inflammatory bowel diseases (IBD).
Fabián O; Kamaradová K
Cesk Patol; 2022; 58(1):27-37. PubMed ID: 35387455
[TBL] [Abstract][Full Text] [Related]
40. [Changes in the number of neuroprotective transmitter containing mucosal nerve fibres in children with ulcerative colitis].
Kamińska B; Landowski P; Gonkowski S; Majewski M; Renke J; Korzon M
Med Wieku Rozwoj; 2006; 10(2):483-91. PubMed ID: 16825719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]